2017
DOI: 10.2147/jn.s119581
|View full text |Cite
|
Sign up to set email alerts
|

Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)

Abstract: Abstract:Restoring functions following spinal cord injury (SCI) was the most challenging task in clinical practice in the past. Fortunately, some effective neurorestorative methods have been exploited in acute, subacute, and chronic phase of SCI. There were no clinical neurorestorative therapeutic guidelines available before this document which can be followed by physicians to manage patients with acute, subacute, and chronic SCI. This guideline will be a helpful reference to physicians to implement their neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 60 publications
0
15
0
Order By: Relevance
“…After 6 months of implantation, the CPN cement clump maintained its monolithic shape and with no apparent disintegration in the cement, but bioresorption occurred at the microscale because the new bone ingrowth to the resorption sites were at the scale of tens of micrometres (Figure 8). These results suggested that the bioresorption rate of CPN was moderate and matched the progression of new bone ingrowth and can be used for fixation in the early stages of spinal injury [27]; this bioresorption behaviour is desirable for maintaining the mechanical stability of CICPS fixation during the progress of the degradation of CPN. We, therefore, expect that CPN would not cause loss of the CICPS fixation before the fracture is healed.…”
Section: Discussionmentioning
confidence: 82%
“…After 6 months of implantation, the CPN cement clump maintained its monolithic shape and with no apparent disintegration in the cement, but bioresorption occurred at the microscale because the new bone ingrowth to the resorption sites were at the scale of tens of micrometres (Figure 8). These results suggested that the bioresorption rate of CPN was moderate and matched the progression of new bone ingrowth and can be used for fixation in the early stages of spinal injury [27]; this bioresorption behaviour is desirable for maintaining the mechanical stability of CICPS fixation during the progress of the degradation of CPN. We, therefore, expect that CPN would not cause loss of the CICPS fixation before the fracture is healed.…”
Section: Discussionmentioning
confidence: 82%
“…Saadoun found that lower ISP and higher SCCP were thought to contribute to the recovery of neurological function by measuring changes in ISP and assessing the AIS grade [10]. Feng pointed out that spinal cord decompression may contribute to the neurological recovery in additional to bony decompression [11].…”
Section: Selection Of Surgical Methodsmentioning
confidence: 99%
“…Aghayan et al reported a draft of Iranian national guidelines for cell therapy manufacturing, which covered all aspects, including ethical issues, manufacturing processes, quality control, transportation, harvesting, storage, and release of cell-based products [66]. Huang [68]. Xiao et al reported on neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells [69], which included standardized training and management procedures for laboratory operators; standardized use and management of materials and equipment; standardized collection, culture, and proliferation of olfactory ensheathing cells obtained from fetal olfactory bulbs; standardized management for cell preservation, transport, and related safeguard measures; and the standardization of a clean environment, routine maintenance, and related tests and examinations.…”
Section: Guidelinesmentioning
confidence: 99%